MétaCan
Menu
Back to cohort
Record W3135279221 · doi:10.9778/cmajo.20200162

Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study

2021· article· en· W3135279221 on OpenAlexafffundvenueabout
William Wong, Alex Haines, Karen E. Bremner, Zhan Yao, Andrew Calzavara, Nicholas Mitsakakis, Jeffrey C. Kwong, Beate Sander, Hla‐Hla Thein, Murray Krahn

Bibliographic record

VenueCMAJ Open · 2021
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsPublic Health OntarioUniversity of WaterlooUniversity Health Network
FundersCanadian Institutes of Health Research
KeywordsMedicineCirrhosisHepatocellular carcinomaInternal medicineRetrospective cohort studyHepatitis B virusCohortHepatitis CHepatitis C virusPopulationLiver transplantationCohort studyIntensive care medicineGastroenterologyTransplantationImmunologyVirusEnvironmental health

Abstract

fetched live from OpenAlex

<h3>Background:</h3> High-quality estimates of health care costs are required to understand the burden of illness and to inform economic models. We estimated the costs associated with hepatitis C virus (HCV) infection from the public payer perspective in Ontario, Canada. <h3>Methods:</h3> In this population-based retrospective cohort study, we identified patients aged 18–105 years diagnosed with chronic HCV infection in Ontario from 2003 to 2014 using linked administrative data. We allocated the time from diagnosis until death or the end of follow-up (Dec. 31, 2016) to 9 mutually exclusive health states using validated algorithms: no cirrhosis, no cirrhosis (RNA negative) (i.e., cured HCV infection), compensated cirrhosis, decompensated cirrhosis, hepatocellular carcinoma, both decompensated cirrhosis and hepatocellular carcinoma, liver transplantation, terminal (liver-related) and terminal (non–liver-related). We estimated direct medical costs (in 2018 Canadian dollars) per 30 days per health state and used regression models to identify predictors of the costs. <h3>Results:</h3> We identified 48 239 patients with chronic hepatitis C, of whom 30 763 (63.8%) were men and 35 891 (74.4%) were aged 30–59 years at diagnosis. The mean 30-day costs were $798 (95% confidence interval [CI] $780–$816) (<i>n</i> = 43 568) for no cirrhosis, $661 (95% CI $630–$692) (<i>n</i> = 6422) for no cirrhosis (RNA negative), $1487 (95% CI $1375–$1599) (<i>n</i> = 4970) for compensated cirrhosis, $3659 (95% CI $3279–$4039) (<i>n</i> = 3151) for decompensated cirrhosis, $4238 (95% CI $3480–$4996) (<i>n</i> = 550) for hepatocellular carcinoma, $8753 (95% CI $7130–$10 377) (<i>n</i> = 485) for both decompensated cirrhosis and hepatocellular carcinoma, $4539 (95% CI $3746–$5333) (<i>n</i> = 372) for liver transplantation, $11 202 (95% CI $10 645–$11 760) (<i>n</i> = 3201) for terminal (liver-related) and $8801 (95% CI $8331–$9271) (<i>n</i> = 5278) for terminal (non–liver-related) health states. Comorbidity was the most significant predictor of total costs for all health states. <h3>Interpretation:</h3> Our findings suggest that the financial burden of HCV infection is substantially higher than previously estimated in Canada. Our comprehensive, up-to-date cost estimates for clinically defined health states of HCV infection should be useful for future economic evaluations related to this disorder.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.022
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.328
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2021
Admission routes4
Has abstractyes

Explore more

Same venueCMAJ OpenSame topicHepatitis C virus researchFrench-language works237,207